|

Using Autologous Bone Marrow Cells With Wharton Gel Exosomes to Stimulate Hepatic Cell Repair in Liver Cirrhosis

RECRUITINGN/ASponsored by Global Stem Cell Center, Baghdad
Actively Recruiting
PhaseN/A
SponsorGlobal Stem Cell Center, Baghdad
Started2026-02-20
Est. completion2026-12-20
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07374185

Summary

the study includes patients with liver cirrhosis irrespective of the stage excluding people with active tumor or other major health issue endangering life, the protocol includes the use of autologous bone marrow derived mononuclear cells harvested from the same patient under local anesthesia ,followed by cell concentration and viability testing , then final product is combined with small volume of 2 cc of Wharton gel exosomes 20 billion per to be administered intravenously.

Eligibility

Healthy volunteers accepted
Inclusion Criteria: any patient with liver cirrhosis , less than 80 years of age -

Exclusion Criteria:

1. active malignancy.
2. severe sepsis.
3. pregnancy. -

Conditions2

Liver CirrhosisLiver Disease

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.